August 17, 2016
Syapse Founder Jonathan Hirsch to Present a New Vision of Precision Medicine in Oncology at 8th Annual Personalized & Precision Medicine Conference
Syapse has been a constant presence in the precision medicine industry, and has recently furthered its involvement in oncology through a partnership with Henry Ford Health Systems.
Jonathan Hirsch, president and founder of Syapse, will be highlighting his company’s efforts at revolutionizing precision cancer care at the 8th Annual Personalized and Precision Medicine Conference. To learn more information, visit: http://personalizedmedicinepartnerships.com/.
In the next few months, Henry Ford Health System will launch the Syapse Precision Medicine Platform software across its cancer care facilities, including the new $10 million destination cancer center in Detroit. Both companies are optimistic that this partnership will advance innovative cancer clinical care, especially for patients in the Midwest. Jonathan Hirsch stated, “We believe that precision medicine will be a core enabling technology for health systems to transform to value-based care.” For more information on this partnership, visit: http://syapse.com/blog/henry-ford-press-release-june-2016/.
One of the longest running conferences in the personalized and precision medicine space, Arrowhead’s 8th Annual Personalized & Precision Medicine Conference will be held October 12-13, 2016 in the San Francisco Bay Area. With several key thought leaders like Jonathan Hirsch presenting, attendees will gain valuable insights into a variety of crucial factors shaping precision and personalized medicine. For more information, download a brochure at: personalizedmedicinepartnerships.com/brochure.
For more information, contact:
John Waslif: Managing Director
866-945-0263 ext 700
Rachel Donlon: Marketing Associate
866-945-0263 ext 701